Meeting
2022 ASCO Annual Meeting
Effect of primary tumor sidedness on the association of tumor-infiltrating lymphocytes with survival of patients with stage III colon cancer (NCCTG N0147) [alliance].
Authors
Bahar Saberzadeh Ardestani
Mayo Clinic, Rochester, MN
Bahar Saberzadeh Ardestani , Nathan R. Foster , Hee Eun Lee , Qian Shi , Steven R Alberts , Thomas C. Smyrk , Frank A. Sinicrope
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3525)
DOI
10.1200/JCO.2022.40.16_suppl.3525
Abstract #
3525
Poster Bd #
319
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance).
First Author: Frank A. Sinicrope
Poster
2019 ASCO Annual Meeting
Relative contribution of clinical and molecular features to outcome within low and high risk T and N groups in stage III colon cancer (CC).
First Author: Frank A. Sinicrope
Poster
2018 ASCO Annual Meeting
Validation of tumor infiltrating lymphocytes (TIL) and tumor budding as predictors of prognosis in patients with stage III colon cancers treated in a FOLFOX-based adjuvant trial: NCCTG N0147 (Alliance).
First Author: Frank A. Sinicrope
Poster
2021 ASCO Annual Meeting
Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).
First Author: Frank A. Sinicrope